Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06720701
Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
View on ClinicalTrials.gov
Summary
Observational, single-center, tissue-based cohort study involving both retrospective and prospective enrollment of patients undergoing CAR-T cell therapy and up to 1 year of prospective follow-up necessary to detect the outcomes required by the study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
125
Start Date
2024-12
Completion Date
2026-12-31
Last Updated
2024-12-06
Healthy Volunteers
No
Conditions
Locations (1)
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Bologna, Italy